Influenza hospitalizations among working age adults (18-64 years) and the potential benefit of recombinant vaccines: USA, 2012-13 through 2022-23 - European Medical Journal

Continue

Influenza hospitalizations among working age adults (18-64 years) and the potential benefit of recombinant vaccines: USA, 2012-13 through 2022-23

Microbiology & Infectious Diseases
Download PDF

The study and publication of this infographic was funded by Sanofi.

Explore the impact of flu hospitalizations on working-age adults and how recombinant influenza vaccine may help reduce this burden.

Discover:

  • Low flu vaccination rates in working-age adults.
  • Flu hospitalization rates in adults 18-64.
  • Potential of recombinant vaccines to reduce hospitalizations.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given